SITAGLIPTIN Metformin NOBEL 50/500 mg 196 pce

7680689670027 CH-68967 A10BD07 07.06.2.

Reimbursement limitations:

JANUMET3

Pour le traitement des patients diabétiques de type 2 qui ne peuvent pas être suffisamment …

SITAGLIPTIN Metformin NOBEL 50/500 mg 196 pce
SITAGLIPTIN Metformin NOBEL 50/500 mg 196 pce
SITAGLIPTIN Metformin NOBEL 50/500 mg 196 pce
1 / 3
google

Details

Product number
6896701
CPT
-
Packaging group
2 x 98
Unit
Tablette(n)
Composition
sitagliptinum 50 mg ut sitagliptini hydrochloridum monohydricum 56.69 mg, metformini hydrochloridum 500 mg, povidonum K 30, cellulosum microcristallinum, crospovidonum, natrii stearylis fumaras corresp. natrium 0.765 mg, Überzug: poly(alcohol vinylicus), E 171, macrogolum 3350, talcum, E 172 (flavum), E 172 (rubrum), E 172 (nigrum), pro compresso obducto.

Articles (1)

Sitagliptin Metformin NOBEL 50 mg/500 mg, Filmtabletten
Filmtabletten
2 x 98
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
01/05/2025
Patient information leaflet
Français
01/05/2025
Patient information leaflet
Italien
01/05/2025
Professional SmPC
Allemand
01/05/2025
Professional SmPC
Français
01/05/2025
Professional SmPC
Italien
01/05/2025

Detailed composition

Substance Quantity Type Category
(N/A)
50.0 MG Substance Wirkstoff (Principe actif)
(N/A)
56.69 MG Substance WIZUS
(N/A)
500.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.765 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK

Reimbursement information

Public price
CHF 52.60
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/05/2025

Authorization holder

NOBEL Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
68967
Drug name
Sitagliptin Metformin NOBEL, Filmtabletten
Galenic form
FILM
ATC Code
A10BD07
Authorization status
Z
Dispensation category
B
First authorization
28/12/2023
Authorization expiration date
27/12/2028
IT number
07.06.2.
Domain
Human medicine
Field of application
Diabetes mellitus Typ 2

Packaging details

Description (FR)
SITAGLIPTIN Metformin NOBEL 50/500 mg 196 pce
Description (DE)
SITAGLIPTIN Metformin NOBEL 50/500 mg 196 Stk
Market launch
01/05/2025
Narcotic (BTM)
No

Original drug

Janumet, Filmtabletten
CHF 41.30
View original

Other packaging sizes

SITAGLIPTIN Metformin NOBEL 50/500 mg 56 pce
56 TABL
View
SITAGLIPTIN Metformin NOBEL 50/850 mg 56 pce
56 TABL
View
SITAGLIPTIN Metformin NOBEL 50/850 mg 196 pce
4 x 49 TABL
View
SITAGLIPTIN Metformin NOBEL 50/1000 mg 56 pce
56 TABL
View
SITAGLIPTIN Metformin NOBEL 50/1000 mg 196 pce
4 x 49 TABL
View